These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 28245474)

  • 1. MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP.
    Du Y; Liu XH; Zhu HC; Wang L; Ning JZ; Xiao CC
    Cell Physiol Biochem; 2017; 41(3):1135-1146. PubMed ID: 28245474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2.
    Zou Q; Wu H; Fu F; Yi W; Pei L; Zhou M
    Arch Biochem Biophys; 2016 Nov; 610():25-32. PubMed ID: 27651238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor RKIP inhibits prostate cancer cell metastasis and sensitizes prostate cancer cells to docetaxel treatment.
    Zhu CX; Li WZ; Guo YL; Chen L; Li GH; Yu JJ; Shu B; Peng S
    Neoplasma; 2018; 65(2):228-233. PubMed ID: 29534584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells.
    Li J; Wang Y; Song Y; Fu Z; Yu W
    Mol Cancer; 2014 Aug; 13():193. PubMed ID: 25128483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cMET promotes metastasis and epithelial-mesenchymal transition in colorectal carcinoma by repressing RKIP.
    Wang S; Ma H; Yan Y; Chen Y; Fu S; Wang J; Wang Y; Chen H; Liu J
    J Cell Physiol; 2021 May; 236(5):3963-3978. PubMed ID: 33151569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis.
    Fu Z; Smith PC; Zhang L; Rubin MA; Dunn RL; Yao Z; Keller ET
    J Natl Cancer Inst; 2003 Jun; 95(12):878-89. PubMed ID: 12813171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.
    Escara-Wilke J; Keller JM; Ignatoski KM; Dai J; Shelley G; Mizokami A; Zhang J; Yeung ML; Yeung KC; Keller ET
    Prostate; 2015 Feb; 75(3):292-302. PubMed ID: 25327941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer.
    Li Y; Tian Z; Tan Y; Lian G; Chen S; Chen S; Li J; Li X; Huang K; Chen Y
    Mol Cancer; 2020 Jun; 19(1):109. PubMed ID: 32580736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of RKIP inhibits cell invasion in glioma cell lines through upregulation of miR-98.
    Chen Z; Cheng Q; Ma Z; Xi H; Peng R; Jiang B
    Biomed Res Int; 2013; 2013():695179. PubMed ID: 24392454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer.
    Ren G; Baritaki S; Marathe H; Feng J; Park S; Beach S; Bazeley PS; Beshir AB; Fenteany G; Mehra R; Daignault S; Al-Mulla F; Keller E; Bonavida B; de la Serna I; Yeung KC
    Cancer Res; 2012 Jun; 72(12):3091-104. PubMed ID: 22505648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.
    He QY; Yi HM; Yi H; Xiao T; Qu JQ; Yuan L; Zhu JF; Li JY; Wang YY; Li LN; Feng J; Lu SS; Xiao ZQ
    Oncotarget; 2015 Jun; 6(18):16422-36. PubMed ID: 25915430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis suppressor genes: a role for raf kinase inhibitor protein (RKIP).
    Keller ET
    Anticancer Drugs; 2004 Aug; 15(7):663-9. PubMed ID: 15269597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma.
    Wang X; Wang X; Zhu Z; Li W; Yu G; Jia Z; Wang X
    Biomed Pharmacother; 2019 Sep; 117():109109. PubMed ID: 31229922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of RKIP promotes radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1 axis via downregulating miR-450b-5p.
    Huang W; Shi G; Yong Z; Li J; Qiu J; Cao Y; Zhao Y; Yuan L
    Cell Death Dis; 2020 Jul; 11(7):504. PubMed ID: 32632129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
    Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
    Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Raf kinase inhibitor protein expression on malignant biological behavior and progression of colorectal cancer.
    Wang Y; Wang LY; Feng F; Zhao Y; Huang MY; Shao Q; Chen C; Sheng H; Chen DL; Zeng ZL; Xu RH; Li YH
    Oncol Rep; 2015 Oct; 34(4):2106-14. PubMed ID: 26238523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of possible mechanisms accounting for raf-1 kinase inhibitor protein downregulation in hepatocellular carcinoma.
    Poma P; Labbozzetta M; Vivona N; Porcasi R; D'Alessandro N; Notarbartolo M
    OMICS; 2012 Nov; 16(11):579-88. PubMed ID: 23095110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells.
    Huang L; Dai T; Lin X; Zhao X; Chen X; Wang C; Li X; Shen H; Wang X
    Biochem Biophys Res Commun; 2012 Aug; 425(2):127-33. PubMed ID: 22809510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
    Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
    Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.